Corrigendum to “Managing Severe Asthma: A Role for the Long-Acting Muscarinic Antagonist Tiotropium”

Author

Hamelmann, E.

Source

BioMed Research International

Issue

Vol. 2019, Issue 2019 (31 Dec. 2019), pp.1-1, 1 p.

Publisher

Hindawi Publishing Corporation

Publication Date

2019-01-29

Country of Publication

Egypt

No. of Pages

1

Main Subjects

Medicine

Abstract EN

In the article titled “Managing Severe Asthma: A Role for the Long-Acting Muscarinic Antagonist Tiotropium” [1], there were errors in the description of Figure 1 and Table 1.

The last sentence of Figure 1 should be updated from “LABA, long-acting β2-agonist” to “IL, interleukin; LABA, long-acting β2-agonist; LTRA, leukotriene receptor antagonist; OCS, oral corticosteroid; SABA, short-acting β2-agonist.” In addition, the last sentence of Table 1 should be updated from “LABA, long-acting β2-agonist; N/A, not applicable; NR, not reported; NS, not significant" to “ICS, inhaled corticosteroid; LABA, long-acting β2-agonist; N/A, not applicable; NR, not reported.”

American Psychological Association (APA)

Hamelmann, E.. 2019. Corrigendum to “Managing Severe Asthma: A Role for the Long-Acting Muscarinic Antagonist Tiotropium”. BioMed Research International،Vol. 2019, no. 2019, pp.1-1.
https://search.emarefa.net/detail/BIM-1127938

Modern Language Association (MLA)

Hamelmann, E.. Corrigendum to “Managing Severe Asthma: A Role for the Long-Acting Muscarinic Antagonist Tiotropium”. BioMed Research International No. 2019 (2019), pp.1-1.
https://search.emarefa.net/detail/BIM-1127938

American Medical Association (AMA)

Hamelmann, E.. Corrigendum to “Managing Severe Asthma: A Role for the Long-Acting Muscarinic Antagonist Tiotropium”. BioMed Research International. 2019. Vol. 2019, no. 2019, pp.1-1.
https://search.emarefa.net/detail/BIM-1127938

Data Type

Journal Articles

Language

English

Notes

Includes bibliographical references

Record ID

BIM-1127938